"10.1371_journal.pone.0080849","plos one","2013-11-22T00:00:00Z","Michal Mielcarek; Tamara Seredenina; Matthew P Stokes; Georgina F Osborne; Christian Landles; Linda Inuabasi; Sophie A Franklin; Jeffrey C Silva; Ruth Luthi-Carter; Vahri Beaumont; Gillian P Bates","Department of Medical and Molecular Genetics, Kings College London, London, United Kingdom; Brain Mind Institute, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland; Cell Signaling Technology, Danvers, Massachusetts, United States of America; CHDI Management Inc./CHDI Foundation Inc., Los Angeles, California, United States of America","Conceived and designed the experiments: MM JCS VB GPB. Performed the experiments: MM TS MPS GFO CL LI SAF. Analyzed the data: MM TS MPS JCS RL-C VB GPB. Contributed reagents/materials/analysis tools: MPS JCS. Wrote the manuscript: MM MPS JCS GPB.","The authors have read the journals policy and have the following conflicts: Cell Signaling Technologies conducted the research through a fee-for-service agreement for Kings College London. Vahri Beaumont is employed by CHDI Management Inc. to provide consulting services to CHDI Foundation. MPS and JCS are employees of Cell Signaling Technologies. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed in the online guide for authors.","2013","11","Michal Mielcarek","MM",11,TRUE,4,7,7,4,TRUE,TRUE,FALSE,0,NA,FALSE
